Загрузка...
α(1)-Antitrypsin deficiency · 5: Intravenous augmentation therapy: current understanding
The biochemical and clinical efficacy of intravenous augmentation therapy in α(1)-antitrypsin deficiency is reviewed, adverse events experienced with this treatment are considered, and its cost effectiveness is discussed.
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMJ Group
2004
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1747086/ https://ncbi.nlm.nih.gov/pubmed/15282394 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/thx.2003.006544 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|